Asia Pacific Rapid Point-of-care Testing For Sickle Cell Anemia Market Size & Outlook
Related Markets
Asia Pacific rapid point-of-care testing for sickle cell anemia market highlights
- The Asia Pacific rapid point-of-care testing for sickle cell anemia market generated a revenue of USD 72.1 million in 2025.
- The market is expected to grow at a CAGR of 11.4% from 2026 to 2033.
- In terms of segment, lateral flow immunoassay was the largest revenue generating type in 2025.
- Paper-Based Rapid Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 72.1 million |
| Market revenue in 2033 | USD 167.3 million |
| Growth rate | 11.4% (CAGR from 2026 to 2033) |
| Largest segment | Lateral flow immunoassay |
| Fastest growing segment | Paper-Based Rapid Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lateral Flow Immunoassay, Paper-Based Rapid Diagnostics, Others Type |
| Key market players worldwide | BioMedomics, Silver Lake Research, Bio-Rad Laboratories Inc, Trivitron Healthcare, Hemex Health, Sysmex Corporation, EKF Diagnostics Holdings PLC, Danaher Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.9% of the global rapid point-of-care testing for sickle cell anemia market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 167.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Scope
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hemex Health | View profile | 1-10 | Portland, Oregon, United States, North America | http://hemexhealth.com/ |
| Silver Lake Research | View profile | 11-50 | Azusa, California, United States, North America | https://www.silverlakeresearch.com/ |
| Halcyon Biomedical | View profile | - | Friendswood, Texas, United States, North America | http://halcyonbiomedical.com |
| BioMedomics | View profile | 1-10 | Morrisville, North Carolina, United States, North America | http://biomedomics.com |
| Transasia Bio Medicals | View profile | 1001-5000 | Mumbai, Maharashtra, India, Asia | http://www.transasia.co.in |
| Trivitron Healthcare | View profile | 5001-10000 | Chennai, Tamil Nadu, India, Asia | http://www.trivitron.com |
| Mylab Discovery Solutions | View profile | 11-50 | Lonavla, Maharashtra, India, Asia | https://mylabdiscoverysolutions.com/ |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | https://www.ekfdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
Asia Pacific rapid point-of-care testing for sickle cell anemia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid point-of-care testing for sickle cell anemia market will help companies and investors design strategic landscapes.
Lateral flow immunoassay was the largest segment with a revenue share of 56.73% in 2025. Horizon Databook has segmented the Asia Pacific rapid point-of-care testing for sickle cell anemia market based on lateral flow immunoassay, paper-based rapid diagnostics, others type covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia Pacific region is emerging as a promising frontier for rapid point-of-care (POC) testing for sickle cell anemia, driven by increasing awareness, advancements in healthcare infrastructure, and rising demand for accessible diagnostics in rural and underserved areas.
Countries such as India, Thailand, and parts of Southeast Asia are witnessing a growing prevalence of hemoglobinopathies like sickle cell anemia and beta thalassemia, particularly among tribal and ethnic minority populations. The demand for rapid diagnostics is also amplified by healthcare systems aiming to decentralize care and reduce the diagnostic burden on tertiary hospitals.
This shift is creating opportunities for local and international diagnostic firms to introduce innovative, cost-effective, and portable testing solutions tailored to low-resource settings. The availability of compact, AI-integrated, and battery-operated devices is helping bridge the diagnostic gap in distant regions.
Reasons to subscribe to Asia Pacific rapid point-of-care testing for sickle cell anemia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific rapid point-of-care testing for sickle cell anemia market databook
-
Our clientele includes a mix of rapid point-of-care testing for sickle cell anemia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific rapid point-of-care testing for sickle cell anemia market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific rapid point-of-care testing for sickle cell anemia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific rapid point-of-care testing for sickle cell anemia market size, by country, 2021-2033 (US$M)
Asia Pacific Rapid Point-of-Care Testing for Sickle Cell Anemia Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
